Aemetis (NASDAQ:AMTX – Get Free Report) was upgraded by StockNews.com to a “sell” rating in a report released on Monday.
Separately, HC Wainwright reissued a “buy” rating and set a $28.00 target price on shares of Aemetis in a report on Monday, December 23rd. One research analyst has rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $12.95.
Check Out Our Latest Report on Aemetis
Aemetis Price Performance
Aemetis (NASDAQ:AMTX – Get Free Report) last announced its quarterly earnings data on Tuesday, November 12th. The specialty chemicals company reported ($0.38) earnings per share for the quarter, beating the consensus estimate of ($0.47) by $0.09. The firm had revenue of $81.44 million during the quarter, compared to the consensus estimate of $77.79 million. During the same period in the prior year, the firm earned ($0.59) earnings per share. On average, sell-side analysts expect that Aemetis will post -2.07 EPS for the current year.
Institutional Investors Weigh In On Aemetis
Several institutional investors have recently bought and sold shares of the stock. State Street Corp raised its position in shares of Aemetis by 36.1% during the 3rd quarter. State Street Corp now owns 699,089 shares of the specialty chemicals company’s stock worth $1,608,000 after buying an additional 185,304 shares in the last quarter. Susquehanna Fundamental Investments LLC raised its holdings in Aemetis by 287.4% during the second quarter. Susquehanna Fundamental Investments LLC now owns 126,078 shares of the specialty chemicals company’s stock worth $379,000 after purchasing an additional 93,536 shares in the last quarter. Wellington Management Group LLP acquired a new stake in Aemetis in the third quarter worth approximately $177,000. Geode Capital Management LLC increased its position in shares of Aemetis by 7.7% during the 3rd quarter. Geode Capital Management LLC now owns 924,293 shares of the specialty chemicals company’s stock valued at $2,126,000 after purchasing an additional 66,031 shares during the period. Finally, Rhumbline Advisers raised its stake in shares of Aemetis by 2,837.1% in the 2nd quarter. Rhumbline Advisers now owns 52,309 shares of the specialty chemicals company’s stock worth $157,000 after buying an additional 50,528 shares in the last quarter. Institutional investors and hedge funds own 27.02% of the company’s stock.
About Aemetis
Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.
Read More
- Five stocks we like better than Aemetis
- How to Calculate Options Profits
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- What is a Special Dividend?
- What Does the Future Hold for Eli Lilly?
- Stock Market Sectors: What Are They and How Many Are There?
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.